GeneGenieDx is a biotech company founded in 2020 in San Jose, California. Our mission is to discover novel biomarkers and translate them into better clinical diagnostic products. Our current focus is to develop cutting-edge bioinformatic and machine learning algorithms to enable the discovery of immune-related diagnostic biomarkers and immunotherapy targets.



Chang Liu, MD,PhD

Associate Professor, Pathology & Immunology, Washington University in St. Louis Medical Director, Barnes-Jewish Hospital HLA Laboratory

Ognjen Nikolic

Co-Founder and Head of Data Science